NCT02159326 - Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions

Drug Interactions

Interventions

DRUG

Microgynon

single oral tablet dose of Microgynon (0.03 mg EE and 0.15 mg LNG, fasted)

DRUG

Riociguat (Adempas,BAY63-2521)

multiple oral tablet doses of 2.5 mg riociguat TID over 12 days and, on the seventh day of this treatment

Trial Locations (1)

Mönchengladbach